The Nifty Midcap and Smallcap indices rallied nearly 7 percent and 10 percent in March, and since February 19, both indices surged 11 percent and 15 percent respectively.
Vesuvius India shares rallied 4.25 percent intraday to touch fresh 52-week high of Rs 1,090 on Tuesday. CNBC-TV18's Varinder Bansal explained reasons for the rally.
Rajat Bose of rajatkbose.com advises selling Kaveri Seeds Company and Vesuvius.
Rajat Bose of rajatkbose.com is of the view that Elder Pharmaceuticals may test Rs 121 and Vesuvius India may hit Rs 757-761.
Vesuvius India is a portfolio bet from next two to three years perspective, says Aashish Tater, Head of Research, Fort Share Broking.
Vesuvius India can test Rs 500 in six to eight month time, says SP Tulsian, sptulsian.com.
Accumulate Vesuvius India on every dip. There is limited downside with definite potential upside of 200% from 3-4 years, says Aashish Tater, Head of Research, Fort Share Broking.